Boston Scientific Corp - Company Profile
Powered by 
All the sales intelligence you need on Boston Scientific Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Boston Scientific Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Boston Scientific Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Boston Scientific Corp (Boston Scientific) is a medical technology company that develops, manufactures, and commercializes devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology, and vascular surgery. Boston Scientific serves hospitals, clinics, outpatient facilities, and medical offices across the world. The company has manufacturing facilities in the US, Ireland, Costa Rica, Brazil, Malaysia and Puerto Rico. It sells products directly and through a network of distributors and dealers in Europe, the Middle East, Africa, Asia Pacific, and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.
Headquarters
United States of America
Address
300 Boston Scientific Way, Marlborough, Massachusetts, 01752-1234
Website
www.bostonscientific.com/en-US/
Telephone
1 508 6834000
No of Employees
59,000
Industry
Medical Equipment
Ticker Symbol & Exchange
BSX (NYSE)
Revenue (2024)
$20.1B
19.9%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
56.3%
(2024 vs 2023)
Market Cap*
$63.4B
Net Profit Margin (2024)
XYZ
30.4%
(2024 vs 2023)
* As of and is in US$
Boston Scientific Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Gynecology Products | Agent |
| Electrophysiology Products | Endotak Reliance |
| Female Pelvic Medicine Products | Contak Renewal |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Acquisitions/Mergers/Takeovers | In May, the company acquired a 34% stake in MiRus LLC. |
| 2026 | Acquisitions/Mergers/Takeovers | In April, the company acquired Valencia Technologies Corporation, a medical technology company. |
| 2026 | Corporate Changes/Expansions | In April, the company invested EUR75 million in its Galway site. |
Competitor Comparison
| Key Parameters | Boston Scientific Corp | Johnson & Johnson | Abbott Laboratories | Medtronic Plc | Nevro Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | Ireland | United States of America |
| City | Marlborough | New Brunswick | Abbott | Dublin | Redwood City |
| State/Province | Massachusetts | New Jersey | Illinois | - | California |
| No. of Employees | 59,000 | 138,200 | 115,000 | 95,000 | 1,099 |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Michael F. Mahoney | President; Chief Executive Officer; Chairman | Executive Board | 2016 | 61 |
| Jonathan R. Monson | Executive Vice President; Chief Financial Officer | Senior Management | 2025 | 52 |
| Jodi Euerle Eddy | Chief Information Officer; Senior Vice President; Chief Digital Officer | Senior Management | 2020 | 53 |
| Kenneth Stein | Senior Vice President; Chief Medical Officer | Senior Management | 2023 | - |
| Miriam O'Sullivan | Chief Human Resources Officer; Senior Vice President | Senior Management | 2025 | 45 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer